查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
远程患者监护：主要趋势、区域分析和市场预测 (2023-2027)
市场调查报告书
商品编码
1186909

远程患者监护：主要趋势、区域分析和市场预测 (2023-2027)

Remote Patient Monitoring: Key Trends, Regional Analysis and Market Forecasts 2023-2027
出版日期: | 出版商: Juniper Research Ltd | 英文 | 商品交期: 最快1-2个工作天内

价格
简介目录

到 2027 年，全球使用远程患者监护 (RPM) 解决方案的患者总数将达到 1.155 亿，占世界人口的 1.4%。 它从 2023 年的 7500 万增长了 67%。 目前，医疗保健系统的压力越来越大，包括缺乏临床人员和医院内的空间有限，增加了对替代医学解决方案的需求。 RPM 允许在压力过大的医疗机构之外提供护理，从而提高医护人员的效率。

本报告分析了全球远程患者监护市场，概述了系统、主要应用领域、总体市场规模趋势展望（未来 5 年）、部门、地区和行业。我们正在调查市场的详细趋势，市场竞争结构，未来增长潜力和挑战，主要公司概况（共15家公司）等。

回答的主要问题

  • 1. 主要市场趋势将如何影响远程患者监护采用预测？
  • 2. 哪些技术将加速远程患者监控？
  • 3. 谁是远程患者监护市场的主要供应商？
  • 4. 阻碍远程患者监测的局限性有哪些？
  • 5. 远程患者监控在哪些地区最为成功？

主要市场统计数据

2023 年市场规模 720 亿美元
2027 年市场规模 1100 亿美元
2023 年到 2027 年的增长率 54%

主要特点

  • 基准行业预测：按地区（共 8 个地区）、按国家（共 60 个国家）
    • 北美
      • 加拿大、美国
    • 拉丁美洲
      • 阿根廷、巴西、智利、哥伦比亚、厄瓜多尔、墨西哥、秘鲁、乌拉圭
    • 西欧
      • 奥地利、比利时、丹麦、芬兰、法国、德国、希腊、爱尔兰、意大利、荷兰、挪威、葡萄牙、西班牙、瑞典、瑞士、英国
    • 中欧和东欧
      • 克罗地亚、捷克共和国、匈牙利、波兰、罗马尼亚、俄罗斯、土耳其、乌克兰
    • 远东/中国
      • 中国、香港、日本、韩国
    • 印度次大陆
      • 孟加拉国、印度、尼泊尔、巴基斯坦
    • 其他亚太国家
      • 澳大利亚、印度尼西亚、马来西亚、新西兰、菲律宾、新加坡、泰国、越南
    • 非洲/中东
      • 阿尔及利亚、埃及、以色列、肯尼亚、科威特、尼日利亚、卡塔尔、沙特阿拉伯、南非、阿拉伯联合酋长国

公司分析

  • Juniper Research 竞争对手排行榜公司： Abbott Laboratories、AMC Health、Biotronik、Boston Scientific、Dreger、GE HealthCare、Masimo、MedM、Medtronic、Omron Corporation、Orion Health、Philips、 Qure4u、罗氏、Vivalink
  • 提到的公司：Acutronic、AFVD、AliveCor、Ascom、AWS、BiolntelliSense、Bionet、Bow Medical、Brainlab、Community Wellness、Doctor Anywhere、Dystonia Europe、EPDA、Luscii、Mazzetti、Partners HealthCare、凤凰城、高通、三星、Triton、大学医院、Verustat

内容

第 1 部分市场趋势和策略

第一章要点与策略建议

第二章市场展望

  • 简介
    • 定义
    • HistoryDe□□vices 用于患者监测
    • 促进远程患者监控的技术
    • 远程病人监护中的人工智能
  • 远程患者监护的优势
  • 远程患者监护的缺点
  • 远程患者监护的驱动因素
  • 远程患者监测的约束因素

第三章市场细分

  • 简介
  • 心血管
    • 用于心血管监测的设备类型
    • 用于心血管疾病的远程医疗的其他方面
    • 智能手錶在心血管疾病中的应用
    • 所需技术的变化和发展
    • 迄今为止的介绍
  • 糖尿病
  • 肥胖
  • 癌症
  • 孕妇
  • 血压计
  • 胎儿/新生儿

第四章区域分析

  • 简介
    • 北美
      • 美国
      • 加拿大
    • 拉丁美洲
      • 阿根廷
      • 巴西
    • 西欧
      • 丹麦
      • 法国
      • 德国
      • 英国
    • 中欧和东欧
      • 波兰
    • 远东/中国
      • 中国
      • 日本
    • 印度次大陆
      • 印度
    • 其他亚太国家
      • 澳大利亚
      • 新加坡
    • 非洲/中东
      • 沙特阿拉伯
      • 南非

第 2 部分竞争排行榜

第 1 章竞争排行榜和供应商概况

  • 远程患者监护供应商简介
    • 雅培实验室
      • 公司
      • 地区
      • 主要客户和合作伙伴
      • 主要产品/服务
      • JuniperResearch 洞察：主要优势和战略机会
    • AMC Health
    • Biotronik
    • Boston Scientific Corporation
    • Drager
    • Ge HealthCare
    • Masimo
    • MedM
    • Medtronic
    • Omron Corporation
    • Orion Health
    • Philips
    • Qure4u
    • Roche
    • Vivalink
  • Juniper Research 排行榜分析方法

第 3 部分数据和预测

第 1 章介绍/市场概述

第 2 章预测概述

  • 简介
  • 用户和收入
    • RPM 用户总数
    • 正在使用的 RPM 设备总数
    • RPM 总收入
  • 来自各种设备的每千次展示收入
    • RPM 设备带来的总收入

第 3 章心臟监测市场预测

  • 介绍
  • 预测方法
  • 用户和收入
    • 使用 RPM 的心脏病患者总数
    • 用于心臟监测的 RPM 设备总数

第 4 章糖尿病监测市场预测

  • 简介
  • 预测方法
  • 用户和收入
    • 使用 RPM 的糖尿病患者总数
    • 用于糖尿病监测的 RPM 设备总数

第 5 章肿瘤监测市场预测

  • 简介
  • 预测方法
  • 用户和收入
    • 使用 RPM 的癌症患者总数
    • 用于肿瘤监测的 RPM 设备总数

第 6 章肥胖监测市场预测

  • 简介
  • 预测方法
  • 用户和收入
    • 使用 RPM 的肥胖患者总数
    • 用于肥胖监测的 RPM 设备总数
简介目录

REPORT OVERVIEW

Juniper Research's “Remote Patient Monitoring” report provides a detailed evaluation of the market, including the adoption of remote patient monitoring within both developing markets and established markets. In addition, this report covers market opportunities; providing strategic insights into the technologies and key drivers that are pushing the space forward. This report analyses the role of 15 leading remote patient monitoring vendors across the market, evaluating them through a competitor leaderboard.

The research suite also contains a detailed dataset; providing forecasts for 60 countries across a number of different metrics, including the number of remote patient monitoring patients, number of remote patient monitoring devices split by device type, including ECG (Electrocardiogram), blood pressure INR (International Normalised Ratio) test, pulse oximeter, glucose monitor, Bluetooth scale and smartwatches, total spend on remote patient monitoring hardware and software and total remote patient monitoring revenue.

Key Market Statistics

Market size in 2023:$72bn
Market size in 2027:$110bn
2023 to 2027 growth:54%

This research suite comprises of:

  • Market Trends & Strategies (PDF)
  • Competitor Leaderboard (PDF)
  • Data & Forecasts (PDF & Excel)
  • 12 Months' Access to harvest Online Data Platform

KEY FEATURES

  • Market Dynamics: A strategic analysis of the major drivers, challenges, and innovations shaping the adoption and development of remote patient monitoring, including the following:
    • COVID-19's impact on the remote patient monitoring market.
    • Future strategic direction and market outlook for remote patient monitoring.
    • Key drivers for remote patient monitoring vendors, including nurse shortages and healthcare system struggles.
  • Regional Analysis: A regional-level analysis of 16 countries, spanning 8 key regions; covering the current deployment level and future outlook of remote patient monitoring. Giving readers insight into the markets with the best opportunities for remote patient monitoring.
  • Benchmark Industry Forecasts: Includes forecasts for the total number of remote patient monitoring patients, number of remote patient monitoring devices, total spend on remote patient monitoring hardware and software and total remote patient monitoring revenue. This data is split by device type and our 8 key forecast regions and 60 countries:
  • North America:
    • Canada, US
  • Latin America:
    • Argentina, Brazil, Chile, Colombia, Ecuador, Mexico, Peru, Uruguay
  • West Europe:
    • Austria, Belgium, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, UK
  • Central & East Europe:
    • Croatia, Czech Republic, Hungary, Poland, Romania, Russia, Turkey, Ukraine
  • Far East & China:
    • China, Hong Kong, Japan, South Korea
  • Indian Subcontinent:
    • Bangladesh, India, Nepal, Pakistan
  • Rest of Asia Pacific:
    • Australia, Indonesia, Malaysia, New Zealand, Philippines, Singapore, Thailand, Vietnam
  • Africa & Middle East:
    • Algeria, Egypt, Israel, Kenya, Kuwait, Nigeria, Qatar, Saudi Arabia, South Africa, United Arab Emirates
  • Juniper Research Competitor Leaderboard: Key player capability and capacity assessment for 15 remote patient monitoring vendors:
    • Abbott Laboratories
    • AMC Health
    • Biotronik
    • Boston Scientific Corporation
    • Drager
    • GE Healthcare
    • Masimo
    • MedM
    • Medtronic
    • Omron Corporation
    • Orion Health
    • Philips
    • Qure4u
    • Roche
    • Vivalink

KEY QUESTIONS ANSWERED

  • 1. How will key market trends affect projected remote patient monitoring adoption?
  • 2. What technologies will accelerate remote patient monitoring?
  • 3. Who are the leading vendors in the remote patient monitoring market?
  • 4. What limitations are there holding back remote patient monitoring?
  • 5. What regions will remote patient monitoring be most successful in?

COMPANIES REFERENCED

  • Included in Juniper Research Competitor Leaderboard: Abbott Laboratories, AMC Health, Biotronik, Boston Scientific, Dräger, GE HealthCare, Masimo, MedM, Medtronic, Omron Corporation, Orion Health, Philips, Qure4u, Roche, Vivalink.
  • Mentioned: Acutronic, AFVD, AliveCor, Ascom, AWS, BiolntelliSense, Bionet, Bow Medical, Brainlab, Community Wellness, Doctor Anywhere, Dystonia Europe, EPDA, Luscii, Mazzetti, Partners HealthCare, Phoenix, Qualcomm, Samsung, Triton, University Hospitals, Verustat.

DATA & INTERACTIVE FORECAST

Key Market Forecast Splits

  • Device Type:
    • ECG
    • Blood Pressure INR Test
    • Pulse Oximeter
    • Glucose Monitor
    • Bluetooth Scale
    • Smartwatches
  • Condition:
    • Cardiac
    • Diabetes
    • Cancer
    • Obesity

Metrics include the number of users leveraging remote patient monitoring, the number of devices in use for remote patient monitoring, total spend on remote patient monitoring software and hardware and total remote patient monitoring revenue.

  • Geographical splits: 60 countries
  • Number of tables: Over 205 tables
  • Number of datapoints: Over 140,000 datapoints

harvest: Our online data platform, harvest, contains the very latest market data and is updated throughout the year. This is a fully featured platform enabling clients to better understand key data trends and manipulate charts and tables; overlaying different forecasts within the one chart - using the comparison tool. Empower your business with our market intelligence centre, and receive alerts whenever your data is updated.

Interactive Excels (IFxl): Our IFxl tool enables clients to manipulate both forecast data and charts, within an Excel environment, to test their own assumptions using the interactive scenario tool and compare selected markets side by side in customised charts and tables. IFxls greatly increase a client's ability to both understand a particular market and to integrate their own views into the model.

FORECAST SUMMARY

The total number of patients using RPM solutions will reach 115.5 million globally by 2027; equating to 1.4% of the total population. This is an increase from only 75 million in 2023. This growth of 67% is driven by greater pressure on healthcare systems, including clinical staff shortages and limited space within hospitals, driving the need for alternative healthcare solutions. RPM enables care to be moved outside of overstressed healthcare facilities; boosting healthcare providers' efficiency.

  • By 2027, there will be 90 million cardiac patients using RPM solutions. Given the high global prevalence of cardiac conditions, the report recommended that healthcare providers use RPM solutions to monitor the heart rate and blood pressure of cardiac patients at home to lower the number of patients in hospital. RPM solutions will also indirectly decrease disease transmission rates and alleviate pressure on healthcare systems by reducing the demand for hospital beds.
  • Healthcare service providers should fully leverage the data generated by the increase in adoption of RPM devices. To maximise the benefits, it recommended that RPM services fully incorporate AI within their solutions to enable healthcare professionals to improve the efficiency of medical triage processes through a predictive proactive healthcare provision model.

Table of Contents

1. Market Trends & Strategies

1. Key Takeaways & Strategic Recommendations

  • 1.1. Key Takeaways & Strategic Recommendations
  • 1.2. Strategic Recommendations

2. Future Market Outlook

  • 2.1. Introduction
    • Figure 2.1: Visualisation of Elements in eHealth
    • 2.1.1. Definitions
      • Figure 2.2: Diagram Displaying How Remote Patient Monitoring Works
    • 2.1.2. Devices Used in Remote Patient Monitoring
      • i. Blood Pressure Cuff
      • ii. Glucose Monitoring
        • Figure 2.3: Visualisation of Continuous Glucose Monitor
      • iii. Electrocardiography Devices
      • iv. Heart Rate Monitors
      • v. Fall Detection
      • vi. Smart Scales
        • Figure 2.4: Visualisation of RPM Process Containing Devices Used
    • 2.1.3. Technology Driving Remote Patient Monitoring
      • i. Cellular RPM devices
      • ii. Bluetooth Remote Patient Monitoring Devices
    • 2.1.4. Artificial Intelligence in Remote Patient Monitoring
  • 2.2. Benefits of Remote Patient Monitoring
    • 2.2.1. Patient Benefits
      • Figure 2.5: Patient Benefits for Remote Patient Monitoring
      • i. Detailed Information on Personalised Health
      • ii. Faster and Better Access to Healthcare Services
      • iii. Patient Outcomes
      • iv. Comfort in Patients' Own Home
      • v. Better Healthcare Opportunities in Rural Communities
      • vi. Greater Oversight and Communications
    • 2.2.2. Healthcare Professional and Provider Benefits
      • Figure 2.6: Provider Benefits for Remote Patient Monitoring
      • i. Improved Patient Outcomes
      • ii. Lower Costs
      • iii. Free Up Spaces in Hospitals
      • iv. Reduced Risk of Disease Transmission
      • v. Combats Clinical Staff Shortages and Optimises Operations
      • vi. Improves Clinical Decision Making
  • 2.3. Disadvantages within Remote Patient Monitoring
    • 2.3.1. Disadvantages of Remote Patient Monitoring for Patients
      • Figure 2.7: Patient Disadvantages for Remote Patient Monitoring
      • i. Patient Isolation
      • ii. Privacy
      • iii. Requires Some Knowledge Surrounding Technology
    • 2.3.2. Disadvantages of Remote Patient Monitoring for Healthcare Providers
      • Figure 2.8: Provider Disadvantages for Remote Patient Monitoring
      • i. Over-reliance on Data
      • ii. Not Consistent Real-Time Monitoring
      • iii. Error Rates of Existing RPM
  • 2.4. Drivers of Remote Patient Monitoring
  • 2.5. Barriers to Remote Patient Monitoring

3. Market Segments

  • 3.1. Introduction
  • 3.2. Cardiovascular
    • 3.2.1. Types of Devices Used for Cardiovascular Monitoring
      • i. Blood Pressure Monitor
      • ii. Anticoagulation Testing Devices
        • Figure 3.1: Image Displaying a INR Testing Device
      • iii. ECG devices
        • Figure 3.2: Visualisation of the Kardia Mobile 6L App and Electrode
      • iv. Pulse Oximetry
    • 3.2.2. Other Aspects of Telemedicine Used in Cardiovascular Diseases
    • 3.2.3. The Use of Smartwatches in Cardiovascular Diseases
    • 3.2.4. Changes and Developments in Technology Required
    • 3.2.5. Deployments to Date
      • Figure 3.3: Total Number of Cardiac Patients Using Remote Patient Monitoring (m), Split by 8 Key Regions, 2022-2027
  • 3.3. Diabetes
    • 3.3.1. Types of Devices Used for Diabetes Monitoring
      • i. Continuous Glucose Monitor
        • Figure 3.4: Visualisation of Continuous Glucose Monitor
      • ii. Smart Insulin Pen
        • Figure 3.5: Visualisation of Smart Insulin Pen
      • iii. Ketone Monitors
    • 3.3.2. Other Aspects of Telemedicine Used in Diabetes
      • Figure 3.6: Visualisation of Dexcom Clarity
    • 3.3.3. The Use of Smartwatches in Diabetes
    • 3.3.4. Changes and Developments in Technology Required
    • 3.3.5. Deployments to Date
      • Figure 3.7: Total Number of Diabetic Patients Using Remote Patient Monitoring (m), Split by 8 Key Regions, 2022-2027
  • 3.4. Obesity
    • 3.4.1. Types of Devices Used for Obesity Management
      • i. Smart Scales
        • Figure 3.8: Visualisation of Smart Scales
      • ii. Blood Pressure Monitors
    • 3.4.2. Other Aspects of Telemedicine in Obesity Monitoring
    • 3.4.3. The Use of Smartwatches in Obesity Monitoring
    • 3.4.4. Changes and Developments Required in Technology
    • 3.4.5. Deployments to Date
      • Figure 3.9: Total Number of Obesity Patients Using Remote Patient Monitoring (m), Split by 8 Key Regions, 2022-2027
  • 3.5. Cancer
    • 3.5.1. Types of Devices Used for Cancer Management
      • i. Digital Thermometer
        • Figure 3.10: Visualisation of TempTraq in Remote Patient Monitoring
    • 3.5.2. Other Aspects of Telemedicine in Cancer Management
    • 3.5.3. The Use of Smartwatches in Cancer Management
    • 3.5.4. Changes and Developments Required in Technology
    • 3.5.5. Deployments to Date
      • Figure 3.11: Total Number of Cancer Patients Using Remote Patient Monitoring (m), Split by 8 Key Regions, 2022-2027
  • 3.6. Maternity
    • Table 3.12: Vital Sign Uses in Tracking Maternity Clinical Implications
    • 3.6.1. Types of Devices Used for Maternity Management
      • i. Blood Pressure Monitors
    • 3.6.2. Other Aspects of Telemedicine in Maternity Management
      • Figure 3.13: Telemedicine Uses Within Pregnancy
    • 3.6.3. Use of Smartwatches in Maternity Management
    • 3.6.4. Changes and Developments Required in Technology
    • 3.6.5. Deployments to Date
  • 3.7. Foetal and Neonatal
    • 3.7.1. Types of Devices Used for Foetal and Neonatal Management
    • 3.7.2. Other Aspects of Telemedicine in Foetal and Neonatal Management
    • 3.7.3. The Use of Smartwatches in Foetal and Neonatal Management
    • 3.7.4. Changes and Developments Required in Technology
    • 3.7.5. Deployments to Date

4. Regional Analysis

  • 4.1. Introduction
    • 4.1.1. North America
      • i. US
        • Table 4.1: Key Health Metrics, 2020-2022 US
      • ii. Canada
        • Table 4.2: Key Health Metrics, 2020-2022 Canada
    • 4.1.2. Latin America
      • i. Argentina
        • Table 4.3: Key Health Metrics, Argentina, 2020-2022
      • ii. Brazil
        • Table 4.4: Key Health Metrics, 2020-2022, Brazil
    • 4.1.3. West Europe
      • i. Denmark
        • Table 4.5: Key Health Metrics, 2020-2022, Denmark
      • ii. France
        • Table 4.6: Key Health Metrics, 2020-2022, France
      • iii. Germany
        • Table 4.7: Key Health Metrics, 2020-2022, Germany
      • iv. UK
        • Table 4.8: Key Health Metrics, 2020-2022, UK
    • 4.1.4. Central & East Europe
      • i. Poland
        • Table 4.9: Key Health Metrics, 2020-2022, Poland
    • 4.1.5. Far East & China
      • i. China
        • Table 4.10: Key Health Metrics, 2020-2022, China
      • ii. Japan
        • Table 4.11: Key Health Metrics, 2020-2022, Japan
    • 4.1.6. Indian Subcontinent
      • i. India
        • Table 4.12: Key Health Metrics, 2020-2022, India
    • 4.1.7. Rest of Asia Pacific
      • i. Australia
        • Table 4.13: Key Health Metrics, 2020-2022, Australia
      • ii. Singapore
        • Table 4.14: Key Health Metrics, 2020-2022, Singapore
    • 4.1.8. Africa & Middle East
      • i. Saudi Arabia
        • Table 4.15: Key Health Metrics, 2020-2022, Saudi Arabia
      • ii. South Africa
        • Table 4.16: Key Health Metrics, 2020-2022, South Africa

2. Competitor Leaderboard

1. Competitor Leaderboard & Vendor Profiles

  • Table 1.1: Juniper Research Competitor Leaderboard: Remote Patient Monitoring Vendors Included & Product Portfolio
  • Figure 1.2: Juniper Research Leaderboard: Remote Patient Monitoring Vendors
  • Table 1.3: Juniper Research Leaderboard: Remote Patient Monitoring Vendors Positioning
  • Table 1.4: Juniper Research Leaderboard Heatmap: Remote Patient Monitoring
  • 1.1. Remote Patient Monitoring Vendor Profiles
    • 1.1.1. Abbott Laboratories
      • i. Corporate
        • Table 1.5: Abbott Laboratories' Financial Snapshot ($b), FY 2019-2021 (FYE 31st December)
      • ii. Geographic Spread
      • iii. Key Clients & Strategic Partnerships
      • iv. High-level View of Offerings
        • Figure 1.6: Visualisation of the Abbott Laboratories' RPM Solution
        • Figure 1.7: Visualisation of the LibreView Process
      • v. Juniper Research's View: Key Strengths & Strategic Opportunities
    • 1.1.2. AMC Health
      • i. Corporate
      • ii. Geographic Spread
      • iii. Key Clients & Strategic Partnerships
      • iv. High-level View of Offerings
      • v. Juniper Research's View: Key Strengths & Strategic Opportunities
    • 1.1.3. Biotronik
      • i. Corporate
      • ii. Geographic Spread
      • iii. Key Clients & Strategic Partnerships
      • iv. High-level View of Offerings
        • Figure 1.8: Biotronik's Remote Patient Monitoring Solution
      • v. Juniper Research's View: Key Strengths & Strategic Opportunities
    • 1.1.4. Boston Scientific Corporation
      • i. Corporate
        • Table 1.9: Boston Scientific's Financial Snapshot ($b), FY 2019-2021
      • ii. Geographic Spread
      • iii. Key Clients & Strategic Partnerships
      • iv. High-level View of Offerings
        • Figure 1.10: Visualisation Showing Boston Scientific's Heart Connect System
        • Figure 1.11: Visualisation of Boston Scientific's Latitude Programming System
      • v. Juniper Research's View: Key Strengths & Strategic Opportunities
    • 1.1.5. Drager
      • i. Corporate
        • Table 1.12: Dräger's Financial Snapshot ($b), FY 2020-2021
      • ii. Geographic Spread
      • iii. Key Clients & Strategic Partnerships
      • iv. High-level View of Offerings
        • Figure 1.13: Visualisation of Dräger's Infinity Gateway Suite
      • v. Juniper Research's View: Key Strengths & Strategic Opportunities
    • 1.1.6. Ge HealthCare
      • i. Corporate
        • Table 1.14: GE HealthCare's Financial Snapshot ($b), FY 2019-2021 (FYE 31st December)
      • ii. Geographic Spread
      • iii. Key Clients & Strategic Partnerships
      • iv. High-level View of Offerings
        • Figure 1.15: Visualisation of GE HealthCare's Mural Virtual Clinical Viewer
      • v. Juniper Research's View: Key Strengths & Strategic Opportunities
    • 1.1.7. Masimo
      • i. Corporate
        • Table 1.16: Masimo's Financial Snapshot ($m), FY2021-2022 (FYE 1st January)
      • ii. Geographic Spread
      • iii. Key Clients & Strategic Partnerships
      • iv. High-level View of Offerings
        • Figure 1.17: Visualisation of Replica Smart Patient Data Management
      • v. Juniper Research's View: Key Strengths & Strategic Opportunities
    • 1.1.8. MedM
      • i. Corporate
      • ii. Geographic Spread
      • iii. Key Clients & Strategic Partnerships
      • iv. High-level View of Offerings
        • Figure 1.18: Visualisation of MedM RPM Software
      • v. Juniper Research's View: Key Strengths & Strategic Opportunities
    • 1.1.9. Medtronic
      • i. Corporate
      • ii. Geographic Spread
      • iii. Key Clients & Strategic Partnerships
      • iv. High-level View of Offerings
        • Figure 1.19: Visualisation of Medtronic Remote Patient Monitoring
      • v. Juniper Research's View: Key Strengths & Strategic Opportunities
    • 1.1.10. Omron Corporation
      • i. Corporate
        • Table 1.20: Omron's Financial Snapshot ($m), FY2021-2022 (FYE 1st January)
      • iii. Geographic Spread
      • iii. Key Clients & Strategic Partnerships
      • iv. High-level View of Offerings
        • Figure 1.21: Visualisation of Omron VitalSight
      • v. Juniper Research's View: Key Strengths & Strategic Opportunities
    • 1.1.11. Orion Health
      • i. Corporate
        • Table 1.22: Orion Health's Financial Snapshot ($m), FY2020-2021 (FYE 31st December)
      • ii. Geographic Spread
      • iii. Key Clients & Strategic Partnerships
      • iv. High-level View of Offerings
      • v. Juniper Research's View: Key Strengths & Strategic Opportunities
    • 1.1.12. Philips
      • i. Corporate
        • Table 1.23: Philips' Financial Snapshot ($b), FY 2019-2021 (FYE 31st December)
      • ii. Geographic Spread
      • iii. Key Clients & Strategic Partnerships
      • iv. High-level View of Offerings
        • Figure 1.24: Visualisation of Philip's Enterprise Telehealth Solutions
      • v. Juniper Research's View: Key Strengths & Strategic Opportunities
    • 1.1.13. Qure4u
      • i. Corporate
      • ii. Geographic Spread
      • iii. Key Clients & Strategic Partnerships
      • iv. High-level View of Offerings
        • Figure 1.25: Visualisation of Qure4u's Remote Patient Monitoring Solution
      • v. Juniper Research's View: Key Strengths & Strategic Opportunities
    • 1.1.14. Roche
      • i. Corporate
        • Table 1.26: Roche's Financial Snapshot ($b), FY 2020-2021 (FYE 31st December)
      • ii. Geographic Spread
      • iii. Key Clients & Strategic Partnerships
      • iv. High-level View of Offerings
      • v. Juniper Research's View: Key Strengths & Strategic Opportunities
    • 1.1.15. Vivalink
      • i. Corporate
      • ii. Geographic Spread
      • iii. Key Clients & Strategic Partnerships
      • iv. High-level View of Offerings
        • Figure 1.27: Visualisation of Vivalink Wearable SP02 Sensor
      • v. Juniper Research's View: Key Strengths & Strategic Opportunities
  • 1.2. Juniper Research Leaderboard Assessment Methodology
    • 1.2.1. Limitations & Interpretations
      • Table 1.28: Juniper Research Competitor Leaderboard Scoring Criteria

3. Data & Forecasting

1. Introduction & Market Summary

  • 1.1. Introduction
    • Figure 1.1: Visualisation of Elements in eHealth
    • 1.1.1. Definitions
      • Figure 1.2: Diagram Displaying how Remote Patient Monitoring Works

2. Forecast Summary

  • 2.1. Introduction
  • 2.2. Users & Revenue
    • 2.2.1. Total Number of RPM Users
      • Figure & Table 2.1: Total Number of RPM Users (m), Split by 8 Key Regions, 2022-2027
    • 2.2.2. Total Number of RPM Devices in Use
      • Figure & Table 2.2: Total Number of RPM Devices (m), Split by 8 Key Regions, 2022-2027
    • 2.2.3. Total RPM Revenue
      • Figure & Table 2.3: Total RPM Revenue ($m), Split by 8 Key Regions, 2022-2027
  • 2.3. RPM Revenue from Each Device
    • 2.3.1. Total Revenue from RPM Devices
      • We expect the total annual revenue from people using RPM to reach $110.3 billion in 2027, up from $71.7 billion in 2023; a CAGR of 13.18% across the forecast period.
      • Figure & Table 2.4: Total Number of RPM devices, Split by 7 Devices, 2022-2027

3. Cardiac Monitoring Market Forecasts

  • 3.1. Introduction
  • 3.2. Forecast Methodology
    • 3.2.1. Users & Revenue Forecast Methodology
      • Figure 3.1: Cardiac Patient RPM Users & Devices Forecast Methodology
  • 3.3. Users & Revenue
    • 3.3.1. Total Number of Cardiac Patients using RPM
      • Figure & Table 3.2: Total Number of Cardiac Patients using RPM (m), Split by 8 Key Regions, 2022-2027
    • 3.3.2. Total Number of RPM Devices Used for Cardiac Monitoring
      • Figure & Table 3.3: Total Number of RPM Devices Used for Cardiac Monitoring (m), Split by 8 Key Regions, 2022-2027

4. Diabetes Monitoring Market Forecasts

  • 4.1. Introduction
  • 4.2. Forecast Methodology
    • 4.2.1. Users & Revenue Forecast Methodology
      • Figure 4.1: Diabetic Patient RPM Users & Devices Forecast Methodology
  • 4.3. Users & Revenue
    • 4.3.1. Total Number of Diabetic Patients Using RPM
      • Figure & Table 4.2: Total Number of Cardiac Patients Using RPM (m), Split by 8 Key Regions, 2022-2027
    • 4.3.2. Total Number of RPM Devices Used for Diabetic Monitoring
      • Figure & Table 4.3: Total Number of RPM Devices Used for Cardiac Monitoring (m), Split by 8 Key Regions, 2022-2027

5. Oncology Monitoring Market Forecasts

  • 5.1. Introduction
  • 5.2. Forecast Methodology
    • 5.2.1. Users & Revenue Forecast Methodology
      • Figure 5.1: Cancer Patient RPM Users & Devices Forecast Methodology
  • 5.3. Users & Revenue
    • 5.3.1. Total Number of Cancer Patients Using RPM
      • Figure & Table 5.2: Total Number of Cardiac Patients Using RPM (m), Split by 8 Key Regions, 2022-2027
    • 5.3.2. Total Number of RPM Devices Used for Cancer Monitoring
      • Figure & Table 5.3: Total Number of RPM Devices Used for Cardiac Monitoring (m), Split by 8 Key Regions, 2022-2027

6. Obesity Monitoring Market Forecasts

  • 6.1. Introduction
  • 6.2. Forecast Methodology
    • 6.2.1. Users & Revenue Forecast Methodology
      • Figure 6.1: Obesity Patient RPM Users & Devices Forecast Methodology
  • 6.3. Users & Revenue
    • 6.3.1. Total Number of Obesity Patients Using RPM
      • Figure & Table 6.2: Total Number of Cardiac Patients Using RPM (m), Split by 8 Key Regions, 2022-2027
    • 6.3.2. Total Number of RPM Devices Used for Obesity Monitoring
      • Figure & Table 6.3: Total Number of RPM Devices Used for Cardiac Monitoring (m), Split by 8 Key Regions, 2022-2027